November 1-2, 2011
Masur Auditorium on the NIH Campus
Building 10, Clinical Center
Bethesda, MD
The 1½ day Summit on Cell Therapy for Cancer included dynamic discussions and lectures by leaders in the field to provide an in-depth review of the state-of the art of cell therapy as a cancer immunotherapy. The program included presentations on the latest research on the following topics.
Topics Addressed
Organizers
David F. Stroncek, MD – National Institutes of Health (NIH)
John O’Shea, MD – National Institute of Arthritis and Musculoskeletal and Skin Diseases, NIH
Cornelis J.M. Melief, MD, PhD – Leiden University Medical Center
Participating Organizations
| AABB (formerly the American Association of Blood Banks) |  |
| American Society for Blood and Marrow Transplantation (ASBMT) |  |
| American Society of Gene & Cell Therapy (ASGCT) |  |
|
Cancer Immunotherapy Trials Network (CITN) |
 |
| National Institutes of Health, Clinical Center, Department of Transfusion Medicine |
